Ester Moya’s Post

🚀 Turning Point for metaBIX Biotech: Tilting the Balance Toward Innovation 🚀 Since our launch in July 2022, metaBIX Biotech has followed an upward trajectory, not only achieving financial milestones but also having a significant impact on animal production. 🌟 Key Achievements: Strategic Expansion: Why are we at a turning point? 🤝 Established a crucial partnership in #Asia to expand our footprint in the #globalmarket. 🤝 Reached an agreement with Farma Animal to start pilot projects in #Brazil, strengthening our presence in Latin America. 🛬 Preparing to expand in the #UnitedStates to capitalize on opportunities in one of the world’s most dynamic markets. 🎯 Our Goal: Our target is to exceed $100 million in sales by 2028, significantly contributing to the improvement of global health. These achievements are not just milestones; they are testimonies of our disruptive technology and our tireless commitment to innovation. At metaBIX Biotech, we do not just keep pace with the industry, we define it. #Innovation #GlobalmetaBIXBiotech #Biotechnology The Ganesha Lab ANII BID Lab

“Innovation is at the core of our business.” — Arjen Lemmen, VP of Corporate Development & Strategy at argenx. I'm happy to share my latest article for BiotechNews & Life Sciences that dives deep into Argenx, an example of biotech innovation emanating from Belgium! In my conversation with Arjen, we explored: • The remarkable transformation of Argenx from a platform company to a global leader with over 1,500 dedicated 'Argonauts' • The successful launch of VYVGART, a groundbreaking treatment for generalized myasthenia gravis • The integral role of innovation in shaping Argenx's culture and operational strategies • The significance of partnerships within the Belgian biotech ecosystem • How resilience and adaptability have allowed Argenx to navigate challenges in clinical trials and financing Argenx’s journey exemplifies how combining scientific rigor with entrepreneurial spirit can lead to groundbreaking advancements in healthcare.

in-cosmetics Global 2024 in Paris concluded on a high note, leaving us feeling grateful and inspired. It was an extraordinary opportunity to build connections with industry leaders around the world. Rossari Biotech extends heartfelt thanks to all who graced our stall with their presence and support. #rossari #rossaribiotech #incosmeticglobal #incosmeticsglobal2024 #tristar #unitop #personalcare #skincare #beautyproducts #health #business #opportunities #chemicaindustry #chemicalsegment #event #exhibition #personalcareproduct #trend #businessopportunities #cosmetics #ingredients #community #networking #development #explore #learninghub #theworld #adapting #largest #newbusinessopportunities #biotech #internationalevent #France #paris #incosmeticsglobal  #incosmetiglobalparis

After a rest week, I’m back with 3 good news from the world of #LifeScience and #sustainability! (And an improved design) 🏥 Okos Diagnostics launched its eco-friendly at-home test kit. ‘ecoFluorecare’ is the world’s first eco-friendly at-home test kit, and Okos developed it with Microprofit Biotech! The first kits will detect COVID, Flu A&B, and RSV, which are some of the most common applications for rapid tests. Now, with Okos’s products, customers can choose more sustainable alternatives to the existing products on the market.  💅 L'Oréal and Debut Partner together to replace its existing cosmetics ingredients. With this collaboration, L'Oréal and Debut Biotech will develop over a dozen bio-identical ingredients. The goal is to replace many cosmetic ingredients across the many L’Oreal products by using advanced biomanufacturing techniques. Joshua Britton, CEO of Debut, highlighted how this partnership helps preserve biodiversity and contributes to a more transparent supply chain for beauty solutions. 💊 Pharmaforum's highlighted the results of prioritizing sustainability. Prioritizing sustainability in drug manufacturing is crucial for long-term growth. The pharmaceutical industry, producing over 200 million metric tonnes of CO2 annually, can significantly reduce its environmental footprint by adopting green chemistry and fusion-based technologies. These innovations not only lower costs but also improve operational efficiency and regulatory compliance. IQVIA highlighted how investments in sustainable practices are rising because they offer a competitive advantage and more innovation. And to communicate them effectively, find out my weekly tip on the carousel 😉

Looking forward to connecting with Bio Companies at Bio Europe Spring to Dive into the compelling reasons why Puerto Rico stands out as a prime destination for Bio Pharma companies growth: - Puerto Rico Talent: Tap into a skilled and diverse workforce, fostering innovation and driving success. - Tax benefits: 1-4% fixed corporate tax rate on eligible income, among other financial incentives. - Part of the U.S.: Puerto Rico offers the same level of operational security, political stability and support, and protections available on the mainland.  - R&D Tax Credit: Up to 50% Tax Credit on qualified Research & Development Activities - Transferable & Sellable. - Innovation: Seamless integration into a thriving tech innovation R&D ecosystem. Last but not least ! Puerto Rico is “The Gateway to the Americas.” From here, you can access the North American, South American, and Caribbean markets with ease and stability under the Made in the USA seal See you soon Bio Europe !!!! #bioeuropespring #Bioconvention #Europe

In March 2024, Proteintech Group marked a significant milestone by establishing its German branch in Planegg-Martinsried, near Munich. Jeff Lee, COO of Proteintech Group, expressed how the team at Invest in Bavaria was essential to supporting their expansion journey. From identifying an ideal location and arranging site visits to the introduction to local networks and navigating administrative requirements, Invest in Bavaria ensured a seamless transition.🚀 Invest in Bavaria provides tailored, free services to help companies establish and grow in Bavaria’s competitive landscape. From offering expert advice on location selection and insights into local market opportunities to facilitating connections with Bavaria’s strong networks and supporting administrative needs, our services are designed to ease the transition and foster integration. This comprehensive support ensures that companies like Proteintech can efficiently enter and thrive in one of Europe’s most dynamic economic regions.🌍 Bavaria’s unique advantages make it a top destination for businesses globally. With advanced infrastructure, it offers extensive connectivity through one of Europe’s largest airports, high-speed rail links, and proximity to major markets, facilitating easy access to international clients and partners. The region boasts a highly educated workforce, supported by renowned institutions like Ludwig-Maximilians-Universität München and the Technische Universität München. Coupled with strong government support for innovation, especially in life sciences, automotive, and IT, Bavaria provides an environment that fosters growth and global competitiveness.🤝 Thinking of expanding to Bavaria, talk to us first! https://lnkd.in/d_HmHfS5 #successinbavaria #services

Excited to meet the leading experts, researchers, and professionals from various disciplines to advance knowledge and collaboration during the business model in practice sessions at the BioBusiness Summer School 2024! I’m eager to connect and share more about the advances and unique challenges in manufacturing and supply of approved cell therapies. #celltherapy #lifesciences #industryinsights #careergrowth #careerdevelopment #leadershipdevelopment

🔔 The Magnet: Connecting innovators in #biotech and #pharma - The inaugural edition of Switzerland Innovation Park Basel Area’s event series focusing on balancing innovation and expectations in AI-driven #drug discovery and development (Organized at the Switzerland Innovation Park Basel Area, Allschwil on 26.11.2024). ➡️ Avisek Ghose and Yury Makhankov were present there to explore these recent trends and to discuss with other #industry leaders. ☑️ During the panel discussion, industry experts like Caoimhe Vallely-Gilroy, Elizabeth Wood, James Gallagher, Joern-Peter Halle and Sai Reddy discussed trends and challenges, such as data availability and integration and addressed setting realistic expectations, securing #investment, avoiding pitfalls etc. ☑️ Another exciting part for us to attend the #networking event and to catch up with many of our peers like Anne Ulvestad, MSc MBA 🌍💡🧬, Dr. Agnieszka Maliszewska, PhD Poorya Amini, Robert F. Siegmund, PhD MBA, Yarina Sheremet, Klaus Gehrlein and many others (list goes on!) 🔜 For one of our scale-up project (#biopharma starting Q2/2025), we are looking for #funding. If you are an Angel #Investor or have any #investment possibility, we will be happy to discuss further. Contact Avisek Ghose at avisek.ghose@inferreconsult.com or Yury Makhankov at yury.makhankov@inferreconsult.com #AIDrugDiscovery #InnovationInLifeSciences #AIInPharma #DrugDevelopment #LifeSciences #AIInnovation #PharmaTrends #IndustryExperts #DataIntegration #NetworkingEvent #businessfunding #scaleupproject #healthcarefunding #investmentopportunity Inferre Consulting Makhankov Consulting

Exciting news! 📢 Mark your calendars for the Bio Talk EU 2024 happening from 9th to 10th September in Berlin. Join #ProBioGen experts as they delve into the latest industry advancements, opportunities, and challenges. Don't miss out on this chance to network with industry peers and learn how #ProBioGen is driving manufacturing excellence. #JoinUs for a taste of the future and accelerate your projects to new heights. See you in Berlin! 🙌 #BioTalkEu2024 #ProBioGen #ManufacturingExcellence #AccelerateYourProjects

Just leaving from Lille from NutrEvent, but exciting times ahead at #CPHIMilan2024! 🌍  From October 8-10, the global pharma community will gather in Milan for the largest gathering of industry leaders, innovators, and partners. With over 62,000 attendees and 2,400+ exhibitors, this event is a prime opportunity to connect and explore advancements across the pharma supply chain. AXXSense will be part of this important event - as a scientific platform specializing in the discovery of novel taste and olfactory modulators, we are at the forefront of innovative solutions that span various sectors, including pharmaceuticals, food, and cosmetics. Our expertise in high-throughput screening and compound profiling will contribute to vital discussions on the future of drug discovery and sensory science. If you're attending, don't miss the chance to connect and engage with thought leaders on topics such as AI in bio-manufacturing, sustainable practices, and patient-centric therapies. Let’s drive innovation and enhance patient access together! 💊💡 Looking forward to seeing everyone in Milan! #CPHIMilan2024 #ScientificPlatform #SensoryScience #FoodIndustry #FragranceIndustry #CosmeticsIndustry #PetFoodIndustry